Guido Hartmann

4.2k total citations · 2 hit papers
38 papers, 3.4k citations indexed

About

Guido Hartmann is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Guido Hartmann has authored 38 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Guido Hartmann's work include Liver physiology and pathology (9 papers), Retinal Diseases and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Guido Hartmann is often cited by papers focused on Liver physiology and pathology (9 papers), Retinal Diseases and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Guido Hartmann collaborates with scholars based in Switzerland, Germany and United Kingdom. Guido Hartmann's co-authors include Walter Birchmeier, K. Michael Weidner, Yasushi Daikuhara, Hirohito Tsubouchi, Matthew S. Sachs, Christa Fonatsch, T Hishida, Harald Rieder, N Arakaki and Wolfgang Haap and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Guido Hartmann

38 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for the identity of human scatter factor and human hepatocyte growth factor.

1991 562 citations K. Michael Weidner, N Arakaki et al. profile →
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

1992 484 citations Guido Hartmann, Walter Birchmeier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Hartmann Switzerland	22	1.4k	1.1k	634	570	365	38	3.4k
Yasuhiro Funahashi Japan	37	2.4k 1.7×	892 0.8×	393 0.6×	2.1k 3.7×	35 0.1×	117	6.0k
Giuseppina Di Stefano Italy	29	1.3k 0.9×	302 0.3×	102 0.2×	425 0.7×	42 0.1×	101	2.3k
Gerrit Los United States	33	1.8k 1.3×	291 0.3×	838 1.3×	1.7k 2.9×	17 0.0×	94	4.1k
Alan Alfieri United States	28	816 0.6×	182 0.2×	361 0.6×	584 1.0×	27 0.1×	66	2.6k
Yoshiharu Miyamoto Japan	27	1.2k 0.9×	404 0.4×	984 1.6×	1.5k 2.7×	12 0.0×	60	3.0k
Yutaka Saitoh Japan	27	1.5k 1.0×	209 0.2×	275 0.4×	262 0.5×	24 0.1×	91	2.9k
Devalingam Mahalingam United States	41	2.9k 2.1×	182 0.2×	406 0.6×	2.0k 3.5×	28 0.1×	186	5.4k
Dashyant Dhanak United States	27	2.0k 1.4×	127 0.1×	409 0.6×	426 0.7×	23 0.1×	59	3.2k
Stephen R. Wedge United Kingdom	39	3.6k 2.6×	224 0.2×	254 0.4×	2.6k 4.5×	28 0.1×	103	7.0k
Donna S. Shewach United States	38	2.8k 2.0×	145 0.1×	409 0.6×	1.8k 3.1×	20 0.1×	98	5.0k

Countries citing papers authored by Guido Hartmann

Since Specialization

Citations

This map shows the geographic impact of Guido Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Hartmann more than expected).

Fields of papers citing papers by Guido Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Hartmann. The network helps show where Guido Hartmann may publish in the future.

Co-authorship network of co-authors of Guido Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Hartmann. A scholar is included among the top collaborators of Guido Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Hartmann. Guido Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nyame, Kwamina, Jian Xiong, Arthur P.H. de Jong, et al.. (2025). PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease. Nature. 642(8067). 474–483. 4 indexed citations

Tiede, Stephan, et al.. (2022). Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2. Frontiers in Neurology. 13. 907317–907317. 14 indexed citations

Regula, Jörg T., Peter Lundh von Leithner, Richard M. FOXTON, et al.. (2017). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 9(7). 985–985. 7 indexed citations

Mazer, Norman A., Dietmar Schwab, Helen M. Byrne, et al.. (2016). What is the biologically relevant KD for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates.. Investigative Ophthalmology & Visual Science. 57(12). 3327–3327. 3 indexed citations

Regula, Jörg T., Peter Lundh von Leithner, Richard Foxton, et al.. (2016). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 8(11). 1265–1288. 241 indexed citations

Iwata, Daiju, Peter Lundh von Leithner, Yin‐Shan Ng, Guido Hartmann, & David T. Shima. (2014). Anti -VEGF/Ang2 bi-specific antibody ameliorates endotoxin-induced uveitis in mice. Investigative Ophthalmology & Visual Science. 55(13). 2354–2354. 4 indexed citations

Leithner, Peter Lundh von, Daiju Iwata, Yin‐Shan Ng, et al.. (2014). Bispecific anti-VEGF/ANG2 antibody exhibits superior efficacy to VEGF monotherapy in a model of spontaneous CNV. Investigative Ophthalmology & Visual Science. 55(13). 2356–2356. 1 indexed citations

Rupanagudi, Khader Valli, Onkar P. Kulkarni, Julia Lichtnekert, et al.. (2013). Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. Annals of the Rheumatic Diseases. 74(2). 452–463. 82 indexed citations

Schmitz, Ralf, et al.. (2013). Automatic chest compression devices—when do they make sense?. The American Journal of Emergency Medicine. 32(1). 82–85. 1 indexed citations

10.

Formentini, Ivan, María Bobadilla, Carolina Haefliger, et al.. (2012). Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Nephrology Dialysis Transplantation. 27(suppl 3). iii81–iii88. 12 indexed citations

11.

Prunotto, Marco, David C. Budd, Giulio Gabbiani, et al.. (2012). Epithelial–mesenchymal crosstalk alteration in kidney fibrosis. The Journal of Pathology. 228(2). 131–147. 46 indexed citations

12.

Hardegger, Leo A., Bernd Kuhn, Lilli Anselm, et al.. (2011). Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments. ChemMedChem. 6(11). 2048–2054. 105 indexed citations

13.

Sayyed, Sufyan G., Mi Heon Ryu, Onkar P. Kulkarni, et al.. (2011). An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney International. 80(1). 68–78. 99 indexed citations

14.

Vijayanand, Pandurangan, Guido Hartmann, Jaymin B. Morjaria, et al.. (2010). Chemokine Receptor 4 Plays a Key Role in T Cell Recruitment into the Airways of Asthmatic Patients. The Journal of Immunology. 184(8). 4568–4574. 80 indexed citations

15.

Hardegger, Leo A., Bernd Kuhn, Lilli Anselm, et al.. (2010). Systematic Investigation of Halogen Bonding in Protein–Ligand Interactions. Angewandte Chemie International Edition. 50(1). 314–318. 423 indexed citations

16.

Gherardi, Ermanno, et al.. (2007). Domain Structure of Hepatocyte Growth Factor/Scatter Factor (HGF/SF). Novartis Foundation symposium. 212. 84–104. 1 indexed citations

17.

Dertinger, Stephen D., et al.. (2002). Actinomyces neuii and Neonatal Sepsis. Infection. 30(3). 178–180. 25 indexed citations

18.

Lin, Shuo, Dario Rusciano, Guido Hartmann, et al.. (1998). C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells. Clinical & Experimental Metastasis. 16(3). 253–265. 16 indexed citations

19.

Hartmann, Guido, Terence D. Prospero, Volker Brinkmann, et al.. (1998). Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Current Biology. 8(3). 125–135. 86 indexed citations

20.

Weidner, K. Michael, N Arakaki, Guido Hartmann, et al.. (1991). Evidence for the identy of human scatter factor and human hepatocyte growth factor.. Ghent University Academic Bibliography (Ghent University). 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact